12/2/24 20:05 | 11/27/24 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | FL | D | | M.d | 126 | 52.30 | 0 | 2 | 9 | 30 | D | | | | | | | | | | | | | | |
12/2/24 20:05 | 11/27/24 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | FL | D | | S.d | -298 | 123.65 | 0 | -2 | -8 | 30 | D | | | | | | | | | | | | | | |
9/25/24 20:54 | 9/23/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | M.d | 105 | 52.27 | 0 | 2 | 10 | 23 | D | | | | | | | | | | | | | | |
9/25/24 20:54 | 9/23/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S.d | -199 | 99.60 | 0 | -2 | -8 | 23 | D | | | | | | | | | | | | | | |
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | S | -133 | 103.94 | 0 | -1 | -5 | 25 | D | | | | | | | | | | | | | | |
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | M.dm | 764 | 51.80 | 0 | 15 | 41 | 51 | D | | | | | | | | | | | | | | |
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.dm | -1,642 | 102.35 | 0 | -16 | -24 | 51 | D | | | | | | | | | | | | | | |
9/19/24 17:50 | 9/17/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | M.d | 118 | 79.63 | 0 | 1 | 6 | 26 | D | | | | | | | | | | | | | | |
9/18/24 19:55 | 9/16/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | M.d | 338 | 58.49 | 0 | 6 | 12 | 52 | D | | | | | | | | | | | | | | |
8/30/24 21:00 | 8/28/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | M.d | 50 | 66.52 | 0 | 1 | 3 | 24 | D | | | | | | | | | | | | | | |
8/30/24 20:56 | 8/28/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | M.d | 78 | 52.27 | 0 | 2 | 7 | 23 | D | | | | | | | | | | | | | | |
8/30/24 20:56 | 8/28/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S.d | -160 | 106.39 | 0 | -2 | -6 | 23 | D | | | | | | | | | | | | | | |
8/26/24 20:15 | 8/22/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.m | -1,986 | 105.34 | 0 | -19 | -28 | 50 | D | | | | | | | | | | | | | | |
8/13/24 17:21 | 8/9/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S | -1,797 | 98.50 | 0 | -18 | -21 | 68 | D | | | | | | | | | | | | | | |
8/9/24 17:52 | 8/8/24 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | FL | DO | CEO | P | 243 | 97.39 | 0 | 3 | 2 | 123 | D | | | | | | | | | | | | | | |
5/17/24 20:00 | 5/9/24 | LGND | Health | Drug | Pharmaceutical Preparations | Gray Nancy Ryan | FL | D | | S | -78 | 83.20 | 0 | -1 | -14 | 6 | D | | | | | | | | | | | | | | |
5/17/24 19:59 | 5/15/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | S.dm | -1,147 | 86.26 | 0 | -13 | -36 | 23 | D | | | | | | | | | | | | | | |
5/17/24 19:59 | 5/17/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | M.d | 385 | 55.71 | 0 | 7 | 42 | 23 | D | | | | | | | | | | | | | | |
5/15/24 19:34 | 5/13/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.m | -1,496 | 84.99 | 0 | -18 | -17 | 86 | D | | | | | | | | | | | | | | |
5/13/24 17:32 | 5/9/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | GC, | M.d | 523 | 52.27 | 0 | 10 | 82 | 22 | D | | | | | | | | | | | | | | |
5/13/24 17:32 | 5/9/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | GC, | S.d | -830 | 83.04 | 0 | -10 | -31 | 22 | D | | | | | | | | | | | | | | |
5/2/24 18:07 | 4/30/24 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | FL | D | | M.d | 126 | 52.30 | 0 | 2 | 2 | 133 | D | | | | | | | | | | | | | | |
4/26/24 18:35 | 4/24/24 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | FL | D | | M.d | 114 | 39.35 | 0 | 3 | 7 | 43 | D | | | | | | | | | | | | | | |
3/27/24 17:47 | 3/25/24 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | FL | DO | CEO | M.d | 919 | 57.39 | 0 | 16 | 15 | 120 | D | | | | | | | | | | | | | | |
3/7/24 13:27 | 3/5/24 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | M.d | 0 | 0.00 | 0 | 3 | 11 | 29 | D | | | | | | | | | | | | | | |
3/7/24 13:27 | 3/5/24 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S.d | -141 | 74.30 | 0 | -2 | -6 | 29 | D | | | | | | | | | | | | | | |
3/6/24 17:28 | 3/5/24 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | M.d | 114 | 39.35 | 0 | 3 | 2 | 131 | D | | | | | | | | | | | | | | |
2/29/24 18:50 | 2/28/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | CA | O | CFO | M.d | 72 | 56.62 | 0 | 1 | 4 | 30 | D | | | | | | | | | | | | | | |
2/29/24 18:50 | 2/28/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | CA | O | CFO | S.d | -12 | 88.46 | 0 | 0 | 0 | 30 | D | | | | | | | | | | | | | | |
9/25/23 16:44 | 9/22/23 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | DO | CEO | P | 238 | 59.38 | 0 | 4 | 6 | 73 | D | | | | | | | | | | | | | | |
5/18/23 17:18 | 5/16/23 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -343 | 77.20 | 0 | -4 | -10 | 38 | D | | | | | | | | | | | | | | |
5/12/23 15:43 | 5/10/23 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | M.d | 0 | 0.00 | 0 | 6 | 33 | 26 | D | | | | | | | | | | | | | | |
5/12/23 15:43 | 5/10/23 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S.d | -494 | 77.13 | 0 | -6 | -20 | 26 | D | | | | | | | | | | | | | | |
5/10/23 19:15 | 5/8/23 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | M.d | 121 | 18.82 | 0 | 6 | 18 | 42 | D | | | | | | | | | | | | | | |
5/10/23 19:15 | 5/8/23 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S.d | -491 | 76.56 | 0 | -6 | -13 | 42 | D | | | | | | | | | | | | | | |
3/28/23 17:00 | 3/24/23 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | CA | O | See Rema | S | -21 | 69.92 | 0 | 0 | -2 | 16 | D | | | | | | | | | | | | | | |
12/20/22 18:36 | 12/16/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | D | | S | -619 | 61.87 | 0 | -10 | -2 | 423 | D | | | | | | | | | | | | | | |
12/14/22 17:00 | 12/12/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | D | | M.d | 256 | 12.78 | 0 | 20 | 5 | 433 | D | | | | | | | | | | | | | | |
11/21/22 19:04 | 11/17/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -783 | 78.32 | 0 | -10 | -2 | 427 | D | | | | | | | | | | | | | | |
11/21/22 19:04 | 11/18/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 128 | 12.78 | 0 | 10 | 2 | 427 | D | | | | | | | | | | | | | | |
11/10/22 16:30 | 11/9/22 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | CA | O | CFO | S | -128 | 75.64 | 0 | -2 | -16 | 9 | D | | | | | | | | | | | | | | |
9/22/22 20:32 | 9/16/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.a | -88 | 88.06 | 0 | -1 | 0 | 366 | D | | | | | | | | | | | | | | |
9/16/22 19:49 | 9/15/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.m | -448 | 89.61 | 0 | -5 | -1 | 364 | D | | | | | | | | | | | | | | |
5/13/22 19:05 | 5/13/22 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | P | 207 | 82.76 | 0 | 3 | 1 | 173 | D | | | | | | | | | | | | | | |
5/10/22 17:33 | 5/9/22 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 175 | 21.92 | 0 | 8 | 2 | 349 | D | | | | | | | | | | | | | | |
3/1/22 16:34 | 2/28/22 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | M.d | 92 | 12.53 | 0 | 7 | 22 | 41 | D | | | | | | | | | | | | | | |
3/1/22 16:34 | 2/28/22 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S.d | -93 | 102.62 | 0 | -1 | -2 | 41 | D | | | | | | | | | | | | | | |
11/17/21 17:06 | 11/16/21 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | M.d | 156 | 32.30 | 0 | 5 | 24 | 25 | D | | | | | | | | | | | | | | |
11/17/21 17:06 | 11/16/21 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | S.d | -783 | 161.86 | 0 | -5 | -16 | 25 | D | | | | | | | | | | | | | | |
11/12/21 19:31 | 11/12/21 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -482 | 160.50 | 0 | -3 | -1 | 335 | D | | | | | | | | | | | | | | |
11/12/21 16:54 | 11/11/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 348 | 28.54 | 0 | 12 | 8 | 167 | D | | | | | | | | | | | | | | |
11/12/21 16:54 | 11/11/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,819 | 163.02 | 0 | -11 | -6 | 167 | D | | | | | | | | | | | | | | |
8/5/21 16:44 | 8/4/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 292 | 29.23 | 0 | 10 | 6 | 165 | D | | | | | | | | | | | | | | |
8/5/21 16:44 | 8/4/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -970 | 109.67 | 0 | -9 | -5 | 165 | D | | | | | | | | | | | | | | |
6/1/21 16:59 | 5/28/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 99 | 56.26 | 0 | 2 | 1 | 164 | D | | | | | | | | | | | | | | |
5/13/21 20:57 | 5/11/21 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | M.d | 49 | 10.12 | 0 | 5 | 16 | 34 | D | | | | | | | | | | | | | | |
2/23/21 17:18 | 2/22/21 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | M.d | 25 | 10.12 | 0 | 3 | 9 | 30 | D | | | | | | | | | | | | | | |
2/12/21 18:23 | 2/10/21 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | S.d | -1,083 | 213.14 | 0 | -5 | -9 | 50 | D | | | | | | | | | | | | | | |
2/12/21 18:23 | 2/11/21 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | M.d | 485 | 195.91 | 0 | 2 | 5 | 50 | D | | | | | | | | | | | | | | |
2/11/21 16:06 | 2/9/21 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | M.d | 166 | 11.33 | 0 | 15 | 150 | 24 | D | | | | | | | | | | | | | | |
2/11/21 16:06 | 2/9/21 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S.d | -3,059 | 208.53 | 0 | -15 | -38 | 24 | D | | | | | | | | | | | | | | |
2/9/21 18:08 | 2/5/21 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 1,394 | 12.16 | 0 | 115 | 50 | 343 | D | | | | | | | | | | | | | | |
2/9/21 18:08 | 2/5/21 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -11,119 | 203.40 | 0 | -55 | -14 | 343 | D | | | | | | | | | | | | | | |
2/5/21 17:03 | 2/4/21 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S.d | -3,230 | 178.50 | 0 | -18 | -39 | 29 | D | | | | | | | | | | | | | | |
2/5/21 17:03 | 2/4/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 1,051 | 23.07 | 0 | 46 | 37 | 168 | D | | | | | | | | | | | | | | |
2/5/21 17:03 | 2/4/21 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -7,879 | 176.86 | 0 | -45 | -21 | 168 | D | | | | | | | | | | | | | | |
1/27/21 19:04 | 1/25/21 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.dm | 1,960 | 16.33 | 0 | 120 | 78 | 273 | D | | | | | | | | | | | | | | |
1/27/21 19:04 | 1/25/21 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.dm | -15,230 | 169.22 | 0 | -90 | -25 | 273 | D | | | | | | | | | | | | | | |
1/27/21 19:02 | 1/27/21 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | M.d | 279 | 113.50 | 0 | 2 | 5 | 53 | D | | | | | | | | | | | | | | |
12/9/20 18:12 | 12/8/20 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 147 | 10.05 | 0 | 15 | 7 | 235 | D | | | | | | | | | | | | | | |
11/10/20 19:41 | 11/9/20 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 201 | 10.05 | 0 | 20 | 10 | 222 | D | | | | | | | | | | | | | | |
11/4/20 16:19 | 11/2/20 | LGND | Health | Drug | Pharmaceutical Preparations | Patel Sunil | CA | D | | P | 83 | 82.52 | 0 | 1 | 4 | 28 | D | | | | | | | | | | | | | | |
8/25/20 19:10 | 8/21/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 165 | 20.39 | 0 | 8 | 5 | 155 | D | | | | | | | | | | | | | | |
8/25/20 19:10 | 8/21/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.dm | -824 | 112.86 | 0 | -7 | -4 | 155 | D | | | | | | | | | | | | | | |
7/9/20 16:28 | 7/7/20 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 302 | 70.01 | 0 | 4 | 2 | 205 | D | | | | | | | | | | | | | | |
6/5/20 16:07 | 6/4/20 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S | -1,322 | 118.59 | 0 | -11 | -21 | 41 | D | | | | | | | | | | | | | | |
3/13/20 18:33 | 3/13/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 44 | 21.92 | 0 | 2 | 1 | 157 | D | | | | | | | | | | | | | | |
2/27/20 20:35 | 2/27/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 142 | 15.89 | 0 | 9 | 6 | 155 | D | | | | | | | | | | | | | | |
2/27/20 20:35 | 2/27/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -795 | 110.00 | 0 | -7 | -4 | 155 | D | | | | | | | | | | | | | | |
2/18/20 17:11 | 2/13/20 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 479 | 9.96 | 0 | 48 | 31 | 205 | D | | | | | | | | | | | | | | |
2/18/20 17:09 | 2/13/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 115 | 14.95 | 0 | 8 | 5 | 154 | D | | | | | | | | | | | | | | |
2/18/20 17:09 | 2/14/20 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -692 | 95.84 | 0 | -7 | -4 | 154 | D | | | | | | | | | | | | | | |
11/13/19 16:07 | 11/12/19 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 22 | 21.92 | 0 | 1 | 1 | 145 | D | | | | | | | | | | | | | | |
9/5/19 19:24 | 9/5/19 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 22 | 21.92 | 0 | 1 | 1 | 144 | D | | | | | | | | | | | | | | |
9/4/19 19:30 | 9/3/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P | 65 | 87.01 | 0 | 1 | 1 | 124 | D | | | | | | | | | | | | | | |
9/3/19 19:34 | 9/3/19 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | P | 43 | 86.18 | 0 | 1 | 3 | 17 | D | | | | | | | | | | | | | | |
8/13/19 13:45 | 8/12/19 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 25 | 21.92 | 0 | 1 | 1 | 143 | D | | | | | | | | | | | | | | |
8/6/19 17:18 | 8/5/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P | 67 | 90.01 | 0 | 1 | 1 | 123 | D | | | | | | | | | | | | | | |
8/6/19 17:17 | 8/5/19 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 74 | 67.72 | 0 | 1 | 2 | 47 | D | | | | | | | | | | | | | | |
8/5/19 19:04 | 8/2/19 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | P | 94 | 93.59 | 0 | 1 | 2 | 49 | D | | | | | | | | | | | | | | |
8/5/19 19:00 | 8/1/19 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | M.d | 81 | 32.30 | 0 | 3 | 12 | 24 | D | | | | | | | | | | | | | | |
8/5/19 18:56 | 8/2/19 | LGND | Health | Drug | Pharmaceutical Preparations | Patel Sunil | CA | D | | P | 96 | 95.98 | 0 | 1 | 4 | 26 | D | | | | | | | | | | | | | | |
8/1/19 14:49 | 7/31/19 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S | -386 | 94.45 | 0 | -4 | -15 | 24 | D | | | | | | | | | | | | | | |
7/31/19 19:26 | 7/31/19 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 177 | 95.45 | 0 | 2 | 1 | 147 | D | | | | | | | | | | | | | | |
7/31/19 18:50 | 7/29/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P.m | 397 | 99.22 | 0 | 4 | 3 | 122 | D | | | | | | | | | | | | | | |
6/12/19 18:51 | 6/11/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P | 27 | 107.01 | 0 | 0 | 0 | 118 | D | | | | | | | | | | | | | | |
6/12/19 18:50 | 6/11/19 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 22 | 21.92 | 0 | 1 | 1 | 141 | D | | | | | | | | | | | | | | |
5/31/19 19:29 | 5/31/19 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 108 | 108.20 | 0 | 1 | 1 | 145 | D | | | | | | | | | | | | | | |
5/31/19 18:27 | 5/29/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P.m | 110 | 109.51 | 0 | 1 | 1 | 117 | D | | | | | | | | | | | | | | |
5/22/19 17:36 | 5/20/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P | 28 | 112.01 | 0 | 0 | 0 | 116 | D | | | | | | | | | | | | | | |
5/16/19 15:54 | 5/14/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P | 28 | 112.51 | 0 | 0 | 0 | 116 | D | | | | | | | | | | | | | | |
5/14/19 19:57 | 5/14/19 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 284 | 113.50 | 0 | 3 | 2 | 144 | D | | | | | | | | | | | | | | |
5/14/19 19:56 | 5/14/19 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | M.d | 45 | 17.88 | 0 | 3 | 11 | 26 | D | | | | | | | | | | | | | | |
5/14/19 19:56 | 5/14/19 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S.d | -282 | 112.92 | 0 | -3 | -9 | 26 | D | | | | | | | | | | | | | | |
3/15/19 14:00 | 3/14/19 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 148 | 9.97 | 0 | 15 | 12 | 140 | D | | | | | | | | | | | | | | |
3/15/19 13:59 | 3/13/19 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | P | 23 | 112.51 | 0 | 0 | 0 | 116 | I | | | | | | | | | | | | | | |
3/15/19 13:58 | 3/13/19 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | P | 286 | 114.29 | 0 | 3 | 2 | 141 | D | | | | | | | | | | | | | | |
1/14/19 09:17 | 1/10/19 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 187 | 65.62 | 0 | 3 | 8 | 40 | D | | | | | | | | | | | | | | |
1/14/19 09:16 | 1/10/19 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 545 | 16.14 | 0 | 34 | 40 | 119 | D | | | | | | | | | | | | | | |
12/17/18 19:58 | 12/17/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 75 | 21.92 | 0 | 3 | 10 | 37 | D | | | | | | | | | | | | | | |
12/12/18 17:32 | 12/12/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 80 | 9.97 | 0 | 8 | 8 | 113 | D | | | | | | | | | | | | | | |
10/25/18 17:44 | 10/24/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 65 | 16.79 | 0 | 4 | 13 | 34 | D | | | | | | | | | | | | | | |
10/15/18 12:55 | 10/12/18 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | M.d | 525 | 103.29 | 0 | 5 | 12 | 48 | D | | | | | | | | | | | | | | |
10/12/18 18:52 | 10/11/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 29 | 14.47 | 0 | 2 | 7 | 30 | D | | | | | | | | | | | | | | |
10/9/18 16:24 | 10/8/18 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | S | -635 | 253.99 | 0 | -3 | -6 | 43 | D | | | | | | | | | | | | | | |
10/2/18 18:24 | 10/1/18 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -688 | 275.04 | 0 | -3 | -9 | 26 | D | | | | | | | | | | | | | | |
10/2/18 18:24 | 10/1/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 194 | 13.80 | 0 | 14 | 15 | 105 | D | | | | | | | | | | | | | | |
10/2/18 18:24 | 10/1/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -3,287 | 273.88 | 0 | -12 | -10 | 105 | D | | | | | | | | | | | | | | |
9/18/18 18:16 | 9/17/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 282 | 100.38 | 0 | 3 | 11 | 28 | D | | | | | | | | | | | | | | |
9/18/18 18:16 | 9/17/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S.d | -705 | 250.69 | 0 | -3 | -9 | 28 | D | | | | | | | | | | | | | | |
9/6/18 10:40 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | M.d | 66 | 13.23 | 0 | 5 | 23 | 27 | D | | | | | | | | | | | | | | |
9/6/18 10:40 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S.d | -1,275 | 255.05 | 0 | -5 | -16 | 27 | D | | | | | | | | | | | | | | |
9/5/18 20:18 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 184 | 14.11 | 0 | 13 | 14 | 103 | D | | | | | | | | | | | | | | |
9/5/18 20:18 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -3,060 | 255.01 | 0 | -12 | -10 | 103 | D | | | | | | | | | | | | | | |
9/5/18 20:00 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | M.d | 1,359 | 69.98 | 0 | 19 | 233 | 28 | D | | | | | | | | | | | | | | |
9/5/18 20:00 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S.d | -4,951 | 254.99 | 0 | -19 | -41 | 28 | D | | | | | | | | | | | | | | |
9/5/18 19:59 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | M.d | 42 | 12.53 | 0 | 3 | 18 | 21 | D | | | | | | | | | | | | | | |
9/5/18 19:59 | 9/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | S.d | -850 | 254.96 | 0 | -3 | -13 | 21 | D | | | | | | | | | | | | | | |
8/31/18 13:22 | 8/30/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -904 | 258.25 | 0 | -4 | -4 | 85 | D | | | | | | | | | | | | | | |
8/29/18 20:35 | 8/29/18 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | M.d | 990 | 85.79 | 0 | 12 | | 7 | D | | | | | | | | | | | | | | |
8/29/18 20:35 | 8/29/18 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | S.d | -4,712 | 256.69 | 0 | -18 | -73 | 7 | D | | | | | | | | | | | | | | |
8/17/18 19:38 | 8/16/18 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S.m | -6,760 | 241.94 | 0 | -28 | -19 | 116 | I | | | | | | | | | | | | | | |
8/17/18 19:38 | 8/16/18 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | S.m | -2,158 | 239.78 | 0 | -9 | -17 | 45 | D | | | | | | | | | | | | | | |
8/17/18 19:37 | 8/16/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.dm | 232 | 14.47 | 0 | 16 | 22 | 89 | D | | | | | | | | | | | | | | |
8/17/18 19:37 | 8/16/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.dm | -8,348 | 241.96 | 0 | -35 | -28 | 89 | D | | | | | | | | | | | | | | |
8/17/18 19:37 | 8/16/18 | LGND | Health | Drug | Pharmaceutical Preparations | Patel Sunil | CA | D | | M.d | 451 | 16.70 | 0 | 27 | | 25 | D | | | | | | | | | | | | | | |
8/17/18 19:37 | 8/16/18 | LGND | Health | Drug | Pharmaceutical Preparations | Patel Sunil | CA | D | | S.d | -10,151 | 240.05 | 0 | -42 | -63 | 25 | D | | | | | | | | | | | | | | |
7/3/18 18:50 | 7/2/18 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -519 | 207.48 | 0 | -3 | -8 | 29 | D | | | | | | | | | | | | | | |
6/4/18 19:01 | 6/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | M.d | 50 | 12.53 | 0 | 4 | 24 | 21 | D | | | | | | | | | | | | | | |
6/4/18 19:01 | 6/4/18 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | S.d | -778 | 194.51 | 0 | -4 | -16 | 21 | D | | | | | | | | | | | | | | |
5/15/18 18:41 | 5/15/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 200 | 16.14 | 0 | 12 | 13 | 107 | D | | | | | | | | | | | | | | |
5/15/18 18:41 | 5/15/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -2,232 | 179.97 | 0 | -12 | -10 | 107 | D | | | | | | | | | | | | | | |
5/11/18 17:32 | 5/10/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 139 | 13.99 | 0 | 10 | 11 | 102 | D | | | | | | | | | | | | | | |
5/11/18 17:32 | 5/10/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,489 | 167.63 | 0 | -9 | -8 | 102 | D | | | | | | | | | | | | | | |
4/3/18 16:50 | 4/2/18 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -401 | 160.43 | 0 | -3 | -8 | 31 | D | | | | | | | | | | | | | | |
3/13/18 18:15 | 3/12/18 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S | -112 | 180.73 | 0 | -1 | -2 | 26 | D | | | | | | | | | | | | | | |
3/9/18 18:28 | 3/8/18 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S.m | -1,318 | 175.73 | 0 | -8 | -5 | 143 | I | | | | | | | | | | | | | | |
3/6/18 18:36 | 3/5/18 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | M.d | 34 | 10.12 | 0 | 3 | 19 | 21 | D | | | | | | | | | | | | | | |
3/6/18 18:36 | 3/5/18 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | S.d | -537 | 160.90 | 0 | -3 | -14 | 21 | D | | | | | | | | | | | | | | |
2/27/18 18:40 | 2/23/18 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S | -530 | 155.00 | 0 | -3 | -2 | 150 | M | | | | | | | | | | | | | | |
2/27/18 18:39 | 2/26/18 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | S.m | -2,616 | 152.37 | 0 | -17 | -24 | 54 | D | | | | | | | | | | | | | | |
2/27/18 18:39 | 2/23/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 89 | 13.77 | 0 | 6 | 7 | 96 | D | | | | | | | | | | | | | | |
2/27/18 18:39 | 2/23/18 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -833 | 152.98 | 0 | -5 | -5 | 96 | D | | | | | | | | | | | | | | |
2/16/18 17:38 | 2/15/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -1,413 | 157.03 | 0 | -9 | -9 | 96 | D | | | | | | | | | | | | | | |
1/26/18 17:31 | 1/24/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -3,713 | 165.00 | 0 | -23 | -17 | 112 | D | | | | | | | | | | | | | | |
1/22/18 19:23 | 1/19/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 262 | 16.14 | 0 | 16 | 14 | 134 | D | | | | | | | | | | | | | | |
1/22/18 19:23 | 1/19/18 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -4,319 | 153.70 | 0 | -28 | -17 | 134 | D | | | | | | | | | | | | | | |
1/11/18 17:55 | 1/10/18 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -363 | 145.00 | 0 | -3 | -7 | 33 | D | | | | | | | | | | | | | | |
12/21/17 06:31 | 12/20/17 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | S | -127 | 137.25 | 0 | -1 | -3 | 27 | D | | | | | | | | | | | | | | |
11/20/17 17:01 | 11/17/17 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S | -3,421 | 140.22 | 0 | -24 | -14 | 155 | I | | | | | | | | | | | | | | |
11/20/17 17:01 | 11/17/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -317 | 140.34 | 0 | -2 | -2 | 141 | D | | | | | | | | | | | | | | |
11/17/17 19:19 | 11/17/17 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | M.d | 40 | 10.12 | 0 | 4 | 24 | 21 | D | | | | | | | | | | | | | | |
11/17/17 19:19 | 11/17/17 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | CA | D | | S.d | -559 | 139.79 | 0 | -4 | -16 | 21 | D | | | | | | | | | | | | | | |
11/17/17 17:14 | 11/16/17 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -709 | 141.71 | 0 | -5 | -12 | 36 | D | | | | | | | | | | | | | | |
11/17/17 17:11 | 11/17/17 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | VP,Finan | S | -936 | 142.63 | 0 | -7 | -45 | 8 | D | | | | | | | | | | | | | | |
11/17/17 17:10 | 11/16/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -751 | 142.53 | 0 | -5 | -4 | 144 | D | | | | | | | | | | | | | | |
10/17/17 17:39 | 10/13/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 250 | 21.92 | 0 | 11 | 8 | 149 | D | | | | | | | | | | | | | | |
9/6/17 20:48 | 9/5/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 105 | 21.00 | 0 | 5 | 4 | 139 | D | | | | | | | | | | | | | | |
9/6/17 20:48 | 9/5/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -650 | 130.00 | 0 | -5 | -3 | 139 | D | | | | | | | | | | | | | | |
8/25/17 17:36 | 8/23/17 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S | -256 | 127.99 | 0 | -2 | -1 | 179 | I | | | | | | | | | | | | | | |
8/10/17 18:40 | 8/9/17 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 69 | 9.97 | 0 | 7 | 8 | 96 | D | | | | | | | | | | | | | | |
8/10/17 18:40 | 8/9/17 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -778 | 127.51 | 0 | -6 | -6 | 96 | D | | | | | | | | | | | | | | |
8/10/17 18:40 | 8/9/17 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S | -2,365 | 126.96 | 0 | -19 | -43 | 24 | D | | | | | | | | | | | | | | |
8/10/17 18:39 | 8/8/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 115 | 21.00 | 0 | 5 | 4 | 139 | D | | | | | | | | | | | | | | |
8/10/17 18:39 | 8/8/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -685 | 125.00 | 0 | -5 | -4 | 139 | D | | | | | | | | | | | | | | |
6/23/17 16:16 | 6/21/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 98 | 21.00 | 0 | 5 | 3 | 139 | D | | | | | | | | | | | | | | |
6/23/17 16:16 | 6/21/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -560 | 120.00 | 0 | -5 | -3 | 139 | D | | | | | | | | | | | | | | |
6/9/17 19:26 | 6/9/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 252 | 21.00 | 0 | 12 | 9 | 139 | D | | | | | | | | | | | | | | |
6/9/17 19:26 | 6/9/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -1,378 | 114.87 | 0 | -12 | -8 | 139 | D | | | | | | | | | | | | | | |
5/15/17 19:05 | 5/12/17 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 78 | 9.97 | 22 | 8 | 9 | 95 | D | 35 | -3 | 8 | 6 | 7 | 7 | 1 | -2 | | | | | | |
5/15/17 19:05 | 5/12/17 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -631 | 112.20 | 22 | -6 | -6 | 95 | D | 35 | -3 | 8 | 6 | 7 | 7 | 1 | -2 | | | | | | |
5/12/17 20:06 | 5/11/17 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S.m | -4,125 | 110.76 | 21 | -37 | -17 | 181 | I | 32 | -5 | 14 | 2 | 5 | 6 | -2 | -2 | | | | | | |
3/21/17 17:49 | 3/20/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -436 | 109.10 | 33 | -4 | -3 | 139 | D | 44 | 10 | -6 | 1 | 1 | 4 | 0 | 0 | 0 | 2 | 1 | | | |
3/10/17 18:03 | 3/8/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S.d | -428 | 107.06 | 33 | -4 | -3 | 143 | D | 48 | 9 | -5 | 2 | 5 | 3 | 4 | 3 | -2 | -1 | -3 | | | |
3/10/17 18:03 | 3/8/17 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | M.d | 158 | 10.05 | 33 | 16 | 12 | 143 | D | 48 | 9 | -5 | 2 | 5 | 3 | 4 | 3 | -2 | -1 | -3 | | | |
3/3/17 18:54 | 3/2/17 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 89 | 9.97 | 33 | 9 | 11 | 93 | D | 53 | 5 | -2 | -3 | 1 | -6 | -3 | -5 | 2 | 5 | 2 | | | |
3/3/17 18:54 | 3/2/17 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -711 | 103.39 | 33 | -7 | -7 | 93 | D | 53 | 5 | -2 | -3 | 1 | -6 | -3 | -5 | 2 | 5 | 2 | | | |
2/28/17 20:30 | 2/27/17 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S.m | -3,403 | 106.35 | 33 | -32 | -13 | 218 | I | 92 | 10 | 4 | 1 | 2 | 0 | 3 | 4 | -1 | 1 | 1 | | | |
11/25/16 17:58 | 11/22/16 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S.m | -1,983 | 107.32 | 33 | -18 | -7 | 250 | I | 98 | 4 | -12 | 3 | 11 | 17 | -2 | 1 | -2 | -3 | -3 | 1 | | |
11/18/16 16:48 | 11/16/16 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | CA | D | | S.m | -666 | 105.28 | 33 | -6 | -2 | 268 | I | 93 | -1 | -11 | -1 | 8 | 11 | 9 | -4 | 1 | 1 | 0 | 0 | | |
11/1/16 20:18 | 10/31/16 | LGND | Health | Drug | Pharmaceutical Preparations | Davis Todd C | CA | D | | M.d | 638 | 45.66 | 29 | 14 | 25 | 70 | D | 76 | 6 | -20 | -28 | -18 | -3 | 0 | 1 | -2 | -2 | 9 | 10 | 16 | |
9/23/16 16:19 | 9/22/16 | LGND | Health | Drug | Pharmaceutical Preparations | Higgins John L | CA | DO | CEO | S | -352 | 117.34 | 33 | -3 | -2 | 123 | D | 151 | 20 | 15 | 3 | 3 | 10 | 6 | 2 | -2 | -12 | -19 | -10 | -9 | |
9/9/16 16:06 | 9/7/16 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -115 | 115.00 | 33 | -1 | -2 | 40 | D | 130 | 23 | 18 | -1 | -15 | 6 | 10 | 8 | 3 | 4 | -12 | -7 | -1 | |
9/9/16 16:05 | 9/1/16 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | M.ad | 76 | 45.60 | 33 | 2 | 4 | 41 | D | 130 | 23 | 18 | -1 | -15 | 6 | 10 | 8 | 3 | 4 | -12 | -7 | -1 | |
9/6/16 18:07 | 9/1/16 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -176 | 105.40 | 33 | -2 | -4 | 39 | D | 100 | 19 | 4 | -9 | -21 | -6 | 4 | 2 | 6 | 5 | -7 | -4 | -2 | |
8/9/16 16:58 | 8/5/16 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 166 | 9.97 | 33 | 17 | 25 | 83 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
8/9/16 16:58 | 8/5/16 | LGND | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,527 | 122.14 | 33 | -13 | -13 | 83 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
8/9/16 16:58 | 8/5/16 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | M.d | 1,662 | 54.76 | 33 | 30 | 400 | 38 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
8/9/16 16:58 | 8/5/16 | LGND | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -2,718 | 123.16 | 33 | -22 | -37 | 38 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
8/2/16 19:46 | 8/1/16 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | CA | D | | S | -138 | 137.57 | 33 | -1 | -2 | 41 | D | 182 | 28 | 37 | 13 | 21 | 8 | 5 | 2 | 0 | -11 | -20 | -27 | -19 | |